Evidence Base™ is the culmination of EBM's extensive consulting experience across many different areas of international CHC, operational and business development, planning and decision making.
A unique and systematic approach, with a core suite of automatic updateable analytical tools easily adapted to leverage any client's available data set, providing faster, better information to help optimise management decision making capability.
Successfully implemented internationally, across Global Regional and Country Leads, Business Development, Category Management, Finance and R&D.
The synthesis of best practice across a multi-client, multi-function, multi-category, multinational experience base means that Evidence Base™ delivers the key analytics & reporting capabilities necessary to leverage the maximum value from your existing data investments.
- Brand and Company Acquisition Search Screening
- Portfolio Analysis and Brand Divestment Selection
- Due Diligence and Valuation
- In and Out Licensing Partner Targeting and Evaluation
- Anti-Trust analysis
- Brand development
- Performance Monitoring & Reporting
- Geographic and Category Strategic Planning
- Rx-OTC Switch Evaluation
- R&D Resource Planning.
EBM has a detailed working knowledge of all main data sources that frame the decision-making process. They have worked with all of the key sales audit data providers (IMS/IQVIA, Nielsen, IRI, Nicholas Hall, Euromonitor); as well as with leading international primary research companies like IPSOS,